CTLA4 and neoplasm: Recently, the CTLA-4 blockade has been shown to promote metabolic fitness and the infiltration of immune cells, especially in glycolysis-low tumors where tumor-specific CD8+ T cell responses correlated with phenotypic and functional destabilization of Tregs towards IFN-γ and TNF-α-producing cells in the tumor in mice model [242].